Fanpeppu
4881.TPharmaceutical
Filed as FunPep Company Limited (2022-08–2026-08)
Financials · Consolidated
| Fiscal year ended | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating income | −¥1.6bn | −¥902m | −¥994m | −¥1.2bn | — |
| Ordinary income | −¥1.6bn | −¥896m | −¥940m | −¥1.2bn | — |
| Net income (owners) | −¥1.9bn | −¥889m | −¥933m | −¥1.2bn | — |
| Total assets | ¥2.0bn | ¥3.1bn | ¥2.5bn | ¥3.0bn | — |
| Net assets / equity | ¥1.5bn | ¥2.5bn | ¥2.3bn | ¥2.7bn | ¥3.2bn |
| Operating cash flow | −¥1.4bn | −¥537m | −¥989m | −¥1.1bn | — |
| EPS (basic) | ¥-50.2 | ¥-31.98 | ¥-39.63 | ¥-61.04 | — |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 3
| Period | Form | Figures |
|---|---|---|
| 2026-01-01 → 2026-06-30 | Half-year | 62 figures · EDINET |
| 2025-01-01 → 2025-06-30 | Half-year | 62 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-year | 60 figures · EDINET |
6 more reports are still being processed.